← Browse by Condition
Medical Condition
melanoma metastatic
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1
NCT06784778
Recruiting
Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.
Enrollment
196 pts
Location
Germany
Sponsor
Pamgene International B.V.
NCT06889766 Phase 1
Recruiting
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Enrollment
9 pts
Location
Switzerland
Sponsor
Centre Hospitalier Universitai...
NCT07076550 Phase 1
Recruiting
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
Enrollment
50 pts
Location
Australia
Sponsor
Alpha-9 Oncology USA Inc.